Skip to main navigation Skip to search Skip to main content

A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycoosis (IM). . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date04/5/19 → 04/4/23

Funding

  • Astellas Pharma Global Development Incorporated: $9,330.00